BA
The Boeing Company
BA has a slight edge over TRN overall, supported by stronger modeled upside and lower modeled downside.
TRN
Trinity Industries, Inc.
TRN offers stronger valuation, but that advantage does not outweigh its weaker overall profile.
BA Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| Stable | |
| Under pressure |
BA's profitability is currently healthy, and its revenue and cash flow are stable, but its balance sheet is under pressure.
TRN Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Strong | |
| Healthy | |
| Strong |
TRN's profitability, cash flow and balance sheet are currently healthy, and its revenue is stable.
BA PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 18x | $172 | — |
| Cheap | 51x | $496 | +189% |
| Fair | 82x | $790 | +360% |
| Expensive | 91x | $876 | +411% |
Historical ranges are pointers, not guarantees.
BA has the edge over TRN in the historical PE scenario, which offers more potential upside but is not a forecast.
TRN PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 7.5x | $30.18 | — |
| Cheap | 12x | $46.62 | +54% |
| Forward | 16x | $30.18 | — |
| Fair | 18x | $72.30 | +140% |
| Expensive | 27x | $109 | +263% |
Historical ranges are pointers, not guarantees.
TRN's PE is in its cheap range at 7.5x. Analysts expect earnings to fall, which would put today's price at 16x next year's earnings, in its fair range.
BA Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Returning to profit | |
| Growth | |
| Improving | |
| Limited | |
| Low |
BA has the edge over TRN on the outlook, with more favorable earnings and revenue expectations.
TRN Forward outlook
| Metric | Outlook |
|---|---|
| Strongly deteriorating | |
| Strong decline | |
| Stable | |
| Strongly weakening | |
| Limited | |
| Moderate |
Analysts expect TRN's earnings and profitability to decline, with its revenue holding steady.
BA Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | $9.66 | +$23.38 |
| Q2 2026 | $2.78 | +$19.33 |
| Q1 2026 | $2.53 | +$20.49 |
| Q4 2025 | $2.48 | +$20.84 |
| Q3 2025 | -$13.72 | -$0.83 |
| Q2 2025 | -$16.55 | -$10.93 |
| Q1 2025 | -$17.96 | -$14.42 |
| Q4 2024 | -$18.36 | -$14.69 |
BA has returned to profit: it earned $9.66 per share over the past year, after losing money the year before.
TRN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $1.87 | -53% |
| Q3 2026 | $4.00 | +251% |
| Q2 2026 | $4.15 | +264% |
| Q1 2026 | $3.12 | +93% |
| Q4 2025 | $3.08 | +88% |
| Q3 2025 | $1.14 | -45% |
| Q2 2025 | $1.14 | -42% |
| Q1 2025 | $1.62 | +8% |
| Q4 2024 | $1.64 | +29% |
TRN has the edge over BA on earnings, with more consistent year-over-year improvement.
BA Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $24.2B | +3.9% |
| Q2 2026 | $24.6B | +8% |
| Q1 2026 | $22.2B | +14% |
| Q4 2025 | $23.9B | +57% |
| Q3 2025 | $23.3B | +30% |
| Q2 2025 | $22.7B | +35% |
| Q1 2025 | $19.5B | +18% |
| Q4 2024 | $15.2B | -31% |
BA has the edge over TRN on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 1.5% | +22 points |
| Q2 2026 | 0.6% | +1.4 points |
| Q1 2026 | 2% | -0.3 points |
| Q4 2025 | 37% | +61 points |
| Q3 2025 | -21% | +12 points |
| Q2 2025 | -0.8% | +5.7 points |
| Q1 2025 | 2.4% | +2.9 points |
| Q4 2024 | -25% | -26 points |
BA's operating margin was 1.5% last quarter, up 22 points from the same quarter a year ago.
TRN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $535.1M | +18% |
| Q2 2026 | $485.1M | -4.2% |
| Q1 2026 | $492M | -16% |
| Q4 2025 | $611.2M | -2.9% |
| Q3 2025 | $454.1M | -43% |
| Q2 2025 | $506.2M | -40% |
| Q1 2025 | $585.4M | -28% |
| Q4 2024 | $629.4M | -21% |
TRN's revenue is recovering but still below its 2019 peak: $535M last quarter, up 18% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 18% | -8.3 points |
| Q2 2026 | 41% | +22 points |
| Q1 2026 | 21% | +3.5 points |
| Q4 2025 | 55% | +37 points |
| Q3 2025 | 26% | +11 points |
| Q2 2025 | 19% | +2 points |
| Q1 2025 | 17% | +2.8 points |
| Q4 2024 | 18% | -0.9 points |
TRN has the edge over BA on profitability, with a higher operating margin.
BA Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $464M | +95% |
| Q2 2026 | $631M | +$831M |
| Q1 2026 | -$1.5B | +$836M |
| Q4 2025 | $375M | +$4.5B |
| Q3 2025 | $238M | +$2.2B |
| Q2 2025 | -$200M | +$4.1B |
| Q1 2025 | -$2.3B | +$1.6B |
| Q4 2024 | -$4.1B | -239% |
BA has the edge over TRN on cash flow, with more consistent year-over-year improvement.
TRN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $49.6M | +41% |
| Q2 2026 | $57.2M | +8.1% |
| Q1 2026 | $91.5M | +36% |
| Q4 2025 | $158.6M | -12% |
| Q3 2025 | $35.3M | -43% |
| Q2 2025 | $52.9M | -77% |
| Q1 2025 | $67.3M | +41% |
| Q4 2024 | $180.1M | +137% |
TRN still generates free cash flow, though less than at its 2021 peak: $357M over the past year.
BA Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 3.0x | Elevated |
| Q2 2026 | 5.7x | High |
| Q1 2026 | 6.0x | High |
| Q4 2025 | 6.9x | High |
| Q2 2024 | 361.8x | High |
| Q1 2024 | 36.1x | High |
| Q4 2023 | 36.4x | High |
| Q3 2023 | 96.1x | High |
BA's net debt is about 3.0 years of its operating earnings (EBITDA), down from more than 20 years a year ago.
TRN Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.2x | Net Cash |
| Q2 2026 | -0.2x | Net Cash |
| Q1 2026 | -0.1x | Net Cash |
| Q4 2025 | -0.2x | Net Cash |
| Q3 2025 | -0.1x | Net Cash |
| Q2 2025 | -0.2x | Net Cash |
| Q1 2025 | -0.1x | Net Cash |
| Q4 2024 | -0.3x | Net Cash |
TRN has the edge over BA on leverage, with a lower net debt burden relative to earnings.
BA Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 31.1 | Neutral |
| Stochastic | 9.6 | Oversold |
BA's weekly RSI is 31 (neutral) and its Stochastic is 10 (oversold).
TRN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 51.5 | Neutral |
| Stochastic | 57.2 | Neutral |
TRN's weekly RSI is 51 (neutral) and its Stochastic is 57 (neutral).
BA PE vs Industrials Sector
| Metric | BA | Sector median | Relative |
|---|---|---|---|
| PE | 18x | 24x | 26% below |
| PE % | 0 | 58 | 58 pts below |
BA is trading at 18x earnings, a 26% discount to the Industrials sector's median of 24x, though its earnings don't support one.
TRN PE vs Industrials Sector
| Metric | TRN | Sector median | Relative |
|---|---|---|---|
| PE | 7.5x | 24x | 69% below |
| PE % | 5 | 58 | 53 pts below |
TRN has the edge over BA on valuation relative to its sector.
BA Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $184.6 | 7.1% below |
| 20 week MA | $203.8 | 16% below |
| 50 week MA | $215.5 | 20% below |
| 100 week MA | $205.9 | 17% below |
| 200 week MA | $200.6 | 14% below |
BA is in a downtrend: it's below all five of its weekly moving averages, and 14% below its 200-week average.
TRN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $27.4 | 10% above |
| 20 week MA | $29.9 | 1% above |
| 50 week MA | $31.0 | 2.5% below |
| 100 week MA | $29.9 | 1% above |
| 200 week MA | $28.8 | 4.9% above |
TRN has the edge over BA on trend strength, trading above more of its moving averages.
BA Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $330.1 | $217.2 | -34% |
| 2021 | $217.2 | $204.2 | -6% |
| 2022 | $204.2 | $189.1 | -7.4% |
| 2023 | $189.1 | $260.7 | +38% |
| 2024 | $260.7 | $180.7 | -31% |
| 2025 | $180.7 | $216.4 | +20% |
| 2026 YTD | $216.4 | $171.6 | -21% |
BA has finished lower in four of the last six years. It's down 21% so far in 2026.
TRN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $22.7 | $26.6 | +17% |
| 2021 | $26.6 | $29.5 | +11% |
| 2022 | $29.5 | $29.9 | +1.5% |
| 2023 | $29.9 | $26.6 | -11% |
| 2024 | $26.6 | $35.5 | +33% |
| 2025 | $35.5 | $27.5 | -22% |
| 2026 YTD | $27.5 | $30.2 | +9.7% |
TRN has the edge over BA on returns for 2026, with the stronger performance.